OmniComm Systems, Inc., an Anju Software Company and strategic software solutions provider to the life sciences industry, has announced its release of IRTMaster Version 5.2, an enhanced product offering to complement their comprehensive eClinical suite. IRTMaster is a fully configurable Interactive Responsive Technology (IRT) system that enables subject screening and randomization, clinical supply management, and investigational product assignment at designated drug dispensing visits. Its unique IRTBuilder workflow allows a single user to implement protocol-specific requirements through a collection of configurable, pre-validated modules without custom programming, dramatically shortening timelines for initial builds and mid-study change requirements.
IRTMaster by itself offers a choice of randomization methodologies (including permuted block, dynamic minimization and Zelen), use of multiple warehouses for managing site supplies, configurable user interface in multiple languages, email notifications and alerts, and streamlined user administration enabling management of multiple studies under a single logon. The system integrates seamlessly with TrialMaster EDC with near-real- time, bi-directional integration, allowing data to pass back and forth, eliminating redundancy in data entry for investigative sites. IRTMaster’s ability to act as a stand-alone system or in conjunction with TrialMaster EDC makes it a desirable solution for customers who require flexibility and scalability in their clinical trial development.
“IRTMaster is specifically designed to reduce the burden of setting up randomization and managing drug supplies within a clinical trial,” said Stephen Johnson, chief revenue officer at OmniComm. “This next generation IRT solution is fully self-service, allowing our clients to either set up randomization and drug shipments on their own, or as a service leveraging our expert clinical analysts. Either way, the configurable and pre-validated modules significantly shorten the time it takes to implement compared to competing IRT solutions.”
IRTMaster joins TrialMaster, TrialOne, AutoEncoder and Acuity as one of OmniComm’s principal offerings available through their fully hosted Software-as-a-Service (SaaS) model or Enterprise Enablement deployment model, and supported by their in-house, round-the-clock customer support team.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.